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Introduction
Benzo(a)pyrene [B(a)P] is a member of a group of
polycyclic aromatic hydrocarbons (PAHs).  PAHs
are substances causing significant environmental
pollution and they have been investigated for their
carcinogenic effects [1-6]. These chemical sub-
stances have been also proved to cause malignancies
in experimental animals [6,7]. In the group of PAHs,
B(a)P has the highest potential to cause cancer
[2,4,8,9]. Furthermore, B(a)P has also mutagenic and
teratogenic effects [2,6, 10-12]. It transforms into
(+)-BP-7-8-oxide by the monooxigenase enzyme,
into (-)-trans-BP-7,8-dihydrodiol by the epoxide
hydrolase enzyme and into (+)-anti-BP-7,8-diol-
9,10-epoxide by the monooxigenase enzyme [1,5].
Thus, this procarcinogen epoxide derivation is
formed by B(a)P, which is metabolised in the liver. It
is the essential carcinogenic metabolite covalently
bound to guanine base of the DNA. 
Doxorubicin, a drug used in cancer therapy, is a
derivative of anthracycline and also known as adri-
amycin [13]. Doxorubicin is bound to sugar-phosphate
structure by cross-linking the DNA after penetrating
into close base pairs of the DNA chain in rapidly
reproducing cancerous cells. It damages the DNA
structure and consequently the RNA synthesis [14,15].
Excretion of doxorubicin occurs predominantly by the
hepatobiliary route and partially by the kidneys. Elim-
ination of the drug slows down if the liver function is
impaired due to the presence of a tumor or some other
disease, and it accumulates in the body unless the dose
intake is reduced [16].  
The objective of this study was to investigate the
possible effects of doxorubicin on the hepatic and
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Abstract: Benzo(a)pyrene (B(a)P) is a polycyclic aromatic hydrocarbon with carcinogenic and toxic effects. Doxorubicin
is a DNA-interacting drug widely used in chemotherapy. In the present study we investigated the effects of doxorubicin on
rats that received benzo(a)pyrene. Sprague-Dawley male rats, 3-4 months old, were divided into 5 groups (n=9 per group).
Group 1 (controls) received normal saline intraperitoneally (i.p.) and intragastrically (i.g.), Group 2 (controls) similarly
received corn oil i.p. and i.g., Group 3 received corn oil soluble benzo(a)pyrene (10mg/kg b.wt every 10 days for 40 days),
Group 4 received doxorubicin (4mg i.p. on 3 consecutive days), Group 5 received doxorubicin for 3 days (as in group 4)
followed by benzo(a)pyrene as in group 3. After twenty-four hours urine samples were collected, heart blood, liver and kid-
ney tissue samples were obtained. Biochemical data were evaluated on urine and blood; liver and kidney tissue samples were
investigated histologically. Uric acid, urine creatinine, creatine clearance, urea nitrogen, serum creatinine values, serum glu-
tamic oxaloacetic transaminase (SGOT, AST), serum glutamic pyruvic transaminase (SGPT, ALT), alkaline phosphatase
(ALP, AP), superoxide dismutase (SOD), catalase (CAT) activities and malondialdehyde (MDA) levels were significantly
different in the 3rd group compared with control groups. Most of the parameters group 5 were statistically similar to con-
trol values. Histological appearance of the liver and the kidney tissue samples supported the improvement in the 5th group.
The result of our study indicated that liver and kidney functions impaired with benzo(a)pyrene may be partially restored by
doxorubicin.
Key words: Benzo(a)pyrene - Doxorubicin - Serum - Superoxide dismutase - Malondialdehyde - Catalase - Kidney - Liver
- Rat
Correspondence: D. Cosan, Büyükdere Mh. Akdogan Sk.
Birkonak Sitesi A Blok D 20, 26060 Eskisehir, Turkey; 
tel.: 05333662680, fax: 02222392220, 
e-mail: dcosan@ogu.edu.tr
Material and methods
Animals. Forty-five male Sprague-Dawley rats weighing 250-
350g were selected from a group of healthy 3-4 month-old rats.
They were divided into five groups containing 9 rats each. The
first group received normal saline intraperitoneally (i.p.) and
intragastrically (i.g.); the second group received corn oil (i.p. and
i.g.). In the third group, 10 mg/kg B(a)P administered intragastri-
cally once in 10 days for 40 days (total 40 mg/kg). The fourth
group received daily 4 mg/kg doxorubicin (i.p.) for 3 consecutive
days (total 12 mg/kg). The fifth group received daily 4 mg/kg
doxorubicin (i.p.) for 3 consecutive days (total 12 mg/kg) fol-
lowing 10 mg/kg B(a)P (i.g.) once in 10 days for 40 days (total
40 mg/kg). Benzo(a)pyrene was dissolved in corn oil, and dox-
orubicin was dissolved in distilled water. Substances were pre-
pared fresh on the day they were applied into rats. Throughout the
period of the study, the rats were allowed access to food and
water ad libitum. Other cleaning considerations in places where
animals live were provided, and it care was taken that animals
were fed with sufficient food and water.
Material samples. At the end of the experiment, each rat was
housed in metabolic cages to collect 24-hour urine samples. Fol-
lowing urine collection, blood samples were obtained from the
heart under ether anaesthesia. Ether anaesthesia was used in all
groups including control group. This short acting agent was pre-
ferred due to its well-known predicted results. Liver and kidney tis-
sue samples of all rats were quickly fixed in 10% neutral buffered
formalin for histology. Tissue samples were embedded in paraffin,
and tissue sections (5 μm thick) were then stained with hema-
toxylin and eosin. After volume and pH values of collected urine
samples were determined, uric acid (Caraway's modified method),
urea nitrogen (Urease-nesslerisation method) and creatinine (Jaffe
alkaline picrate assay) values were measured spectrophotometri-
cally. Hemoglobin (oxyhemoglobin method) and hematocrit values
of blood samples taken inside hemoglobin and hematocrit pipettes
were determined. Serum creatinine, AST (SGOT Chroma test kit),
ALT (SGPT Chroma test kit) and AP (ALP Chroma test kit) activ-
ities of blood samples kept inside normal tubes were measured
spectrophotometrically. Levels of superoxide dismutase (SOD)
[17], catalase activity (CAT) [18] and malondialdehyde (MDA)
(TBA reaction) [19] products of lipid peroxidation, were deter-
mined by preparing hemolysates of blood samples taken into
EDTA tubes. All spectrophotometric measurements were done by
means of Shimadzu UV-1601 digital spectrophotometer (Shi-
madzu Corp., Kyoto, Japan). 
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Table 1. Values of urine and creatinine levels in all groups (n=9 in each group). Values expressed as mean ± SD.
Table 2. Levels of hemoglobin, hematocrit, AST, ALT and AP in all groups (n=9 in each groups). Values expressed as mean ± SD.
p<0.05*, p<0.01**, p<0.0001***
p<0.05*, p<0.01**, p<0.001***
Ethical issues. This study was approved by the local ethics com-
mittee of Eskisehir Osmangazi University of Animal Experiments.
Statistical analysis. All data were expressed as means ± standard
deviation. Differences between the means of various results were
assessed for statistical significance by ANOVA, followed by
Tukey's multiple comparison tests. A p value <0.05 was considered
to indicate statistical significance.
Results
All parameters between the saline group and the corn
oil group (control groups) were found statistically
insignificant. Urine volumes of group 4 (p<0.001) and
group 5 (p<0.01) decreased statistically compared with
control groups, and the pH level was decreased only in
group 3 (p<0.001) compared with control groups.
Urine values for uric acid, urea nitrogen, creatinine
and creatine clearance of group 3 (p<0.001), group 4
(p<0.05) and group 5 (p<0.01) were decreased, and
serum creatinine values were increased in group 3
(p<0.001), group 4 (p<0.05) and group 5 (p<0.01)
compared with control groups (Table 1). Values for
hemoglobin and hematocrit were statistically insignif-
icant between the control and other groups. While AST
enzyme activity increased only in group 3 (p<0.001),
ALT enzyme activity increased in group 3 (p<0.001),
group 4 (p<0.05) and group 5 (p<0.01) compared with
control groups. AP decreased in group 3 (p<0.001),
group 4 (p<0.05) and group 5 (p<0.01) (Table 2). SOD
and MDA values increased in group 3 (p<0.001) and
group 5 (p<0.05) compared with control groups, but
CAT decreased in group 3 (p<0.001), group 4 (p<0.05)
and group 5 (p<0.01) (Table 3).
Histology of sections of liver and kidney in the con-
trol and corn oil groups was normal (Fig. 1 and 2). In
the B(a)P group, deformations occurred in the cord-
like arrangements of hepatocytes seen in the liver.
Congestion of sinusoids in some areas and Kupffer cell
hyperplasia were also observed. Furthermore, vacuolar
degenerations of hepatocytes in the periportal zone
(Fig. 3) were common, and increased numbers of poly-
morphonuclear cells and mononuclear cells were also
noted. Hyperemia was observed in some places of kid-
ney cross-sections; vacuolization and desquamation of
proximal tubule cells and dilatation of some tubules
were also observed (Fig. 4). These findings were
insignificant in liver and kidney cross sections of the
doxorubicin treated group. In the group where B(a)P
and doxorubicin were administered, hepatotoxicity
and nephrotoxicity partly decreased compared to the
B(a)P group (Fig. 5 and 6). 
Discussion
Increases or decreases in urine uric acid, serum creati-
nine and creatinine clearance values indicate renal fail-
ure, and decreases in urea nitrogen value indicate both
renal and hepatic failure [20]. Review of the literature
on studies performed with B(a)P, lack any reports
investigating uric acid and urea nitrogen in urine. 6-
nitrochrysene (6-NC), an environmental contaminant
like B(a)P, has been shown to be carcinogenic in the
liver and the colon [21].  Results of their study showed
decreased serum uric acid and blood urea nitrogen val-
ues in Syrian golden hamsters that received 6-NC. In
another study, blood urea nitrogen and serum creati-
nine values in Sprague-Dawley rats, which received 10
mg/kg B(a)P i.p. once a week for 5 weeks, did not dif-
fer from the control group [22]. In our study, the appli-
cation of 10 mg/kg B(a)P i.g. once in 10 days for 40
days reduced urine uric acid, urea nitrogen, creatinine
and creatine clearance, but serum creatinine values
were increased. 
It has been reported that increased blood urea nitro-
gen (BUN) and serum creatinine levels, decreased cre-
atine clearance in doxorubicin treated Sprague-Daw-
ley rats compared to the control [23]. Another study
has indicated significant serum creatine, uric acid and
BUN increase in doxorubicin-treated rats compared to
the control. In doxorubicin-treated Wistar rats, urea
nitrogen and serum creatinine levels increased [24].
Although decreases in serum creatinine and creatinine
clearance in these studies are similar to our results,
other findings differ from ours. In our doxorubicin-
treated group, uric acid, urine urea nitrogen, urine cre-
atinine and creatine clearance decreased, and serum
creatinine value increased.
A study performed on Wistar rats has noted
increases in AST, ALT and AP enzyme activities in the
group treated with 10 mg/rat B(a)P [25]. As our study
indicated a decrease in AP, this research and our study
indicate difference for AP values. Another study per-
formed on Wistar Lewis rats has indicated no differ-
ence in AST activities between the control and the
group treated with 1.5 mg/kg doxorubicin i.p. 2 times
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Table 3. Levels of SOD, CAT and MDA in all groups (n=9 in each
groups). Values expressed as mean ± SD.
a week, and it has also indicated a decrease in ALT and
AP activities compared with controls [26]. AST and
AP values in our study are in accordance with their
results, but the increase in ALT value differs from the
results of their study. 
In Sprague-Dawley rats that received 20 mg/kg
B(a)P, SOD activity in erythrocytes has been measured
at different times. SOD activity has significantly
increased 6 hours after the application; it has peaked
after 24 hours and then reached control levels after 96
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Fig. 1. Photomicrograph showing liver tissue section of the first group (H+E, magnification ×132). Fig. 2. Photomicrograph showing renal
cortex of the rat from the first group (H+E, magnification ×132). Fig. 3. Photomicrograph showing liver tissue section of the rat from 3rd
group. Note the expanded Kiernan areas, increasing of the fiber structures and extensive hydropic degenerations in hepatocytes (H+E,
magnification ×132). Fig. 4. Photomicrograph showing renal section of the rat from 3rd group. Note the hyperaemia, dilatations in distal
tubules and desquamations (H+E, magnification ×66). Fig. 5. Photomicrograph showing liver tissue section of the rat from 5th group.
Note the slight sinusoidal congestions, hydropic degenerations in some hepatocytes (H+E, magnification ×132). Fig. 6. Photomicrograph
showing renal cortex of the rat from 5th group. Note the slight hyperemias, and proximal tubules are observed nearly normal appearance
compared with the appearances in control group (H+E, magnification ×132). 
hours. CAT activity has also significantly increased 12
hours after application; it peaked at 24 hours and
reached control levels after 96 hours. MDA was not
changed after 6 hours; increased significantly at 12
hours, and the increase continued more than 96 hours
[27,28]. In another study performed on Wistar rats,
SOD activity has been significantly decreased in B(a)P
treated group [25]. It has been also reported that 7.5
mg/kg doxorubicin induces superoxide dismutase [14].
In our study, SOD activity and MDA increased while
CAT activity decreased following a long-term B(a)P
treatment, and  SOD activity slightly decreased in 4
mg/kg doxorubicin treated group. 
In Hodgkin's lymphoma patients treated with dox-
orubicin, bleomycin, vincristine and dexamethasone
(ABVD treatment protocol), serum SOD and CAT lev-
els decreased and MDA increased on day 1 and day 7
compared to the pre-treatment period [29]. Our study
showed that SOD and MDA values in rats treated with
doxorubicin after B(a)P application were higher than
the controls at the end of the experiment, and that CAT
value was lower compared to controls. 
In our study, normal classical lobule and portal area
structure was observed in liver cross sections of the
control groups. However, there was quite remarkable
degeneration of hepatocytes in the periportal areas of
group 3 and hydropic degeneration of hepatocytes in
group 4. Hepatotoxicity was considerably decreased
and common parenchymal degenerations were
improved in the doxorubicin and B(a)P treated group
5 compared to the B(a)P applied group 3. Normal
cortex and medulla structures were observed in kid-
ney sections of the control groups. Hyperemia was
observed in some places of intertubular vessels in
kidney cortex and medulla of group 3, and there was
also vacuolisation and desquamation in proximal
tubule cells. Hydropic degeneration and hyperemia
was observed in some proximal tubule cells of  group
4, though not as much as the benzo(a)pyrene group.
Hepatotoxicity and nephrotoxicity were considerably
decreased in group 5, and the degenerative changes
seen in kidney sections group 5 were interpreted as
reversible. 
In our study, B(a)P application to rats damaged
liver and kidney functions as measured by urine
parameters, AST, ALT and AP levels. The histological
appearance of liver and kidney also supported all these
findings. However, there were some negative changes
in the doxorubicin-treated group. Much worse effects
expected to occur when benzo(a)pyrene and doxoru-
bicin are used together did not occur, and doxorubicin
was shown not to have further destructive effect on
already damaged tissues or functions. We conclude
that tissue degeneration due to benzo(a)pyrene appli-
cation may be partially improved following doxoru-
bicin treatment. We believe that comparative data
obtained from other future investigations would
advance our knowledge of the effects of doxorubicin
on the pathogenesis of B(a)P toxicity. 
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